Amyloidosis News and Research

RSS
Amyloidosis is the term applied to a group of conditions caused by deposits of an abnormal protein called amyloid. This rare but serious condition affects between 1 and 5 people in every 100,000 each year in the UK. The condition is mainly seen among the elderly.
Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Key mechanism for systemic delivery of RNAi therapeutics using LNPs discovered

Key mechanism for systemic delivery of RNAi therapeutics using LNPs discovered

Advances in development of “lipidoid” formulations for systemic delivery of RNAi therapeutics

Advances in development of “lipidoid” formulations for systemic delivery of RNAi therapeutics

Mayo Clinic licenses non-exclusive rights to Expression Pathology's Liquid Tissue patent

Mayo Clinic licenses non-exclusive rights to Expression Pathology's Liquid Tissue patent

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting

Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

Symptomless blood disorder MGUS not a precursor of serious diseases

Symptomless blood disorder MGUS not a precursor of serious diseases

New small molecule approach to Alzheimer's disease treatment

New small molecule approach to Alzheimer's disease treatment

Lasers show potential to 'zap' amyloid proteins

Lasers show potential to 'zap' amyloid proteins

The emerging role of infection in Alzheimer’s

The emerging role of infection in Alzheimer’s

FDA approves Arcalyst for treatment of rare inflammatory syndromes

FDA approves Arcalyst for treatment of rare inflammatory syndromes

New insight into how cystatin C may lower the risk for Alzheimer's disease

New insight into how cystatin C may lower the risk for Alzheimer's disease

Chemotherapy and blood stem cell transplantation results in long-term survival for amyloidosis patients

Chemotherapy and blood stem cell transplantation results in long-term survival for amyloidosis patients

Stem cell procedure successfully treats amyloidosis patients

Stem cell procedure successfully treats amyloidosis patients

Foie gras can speed amyloid development

Foie gras can speed amyloid development

New aspect of prion disease - agent causes heart damage

New aspect of prion disease - agent causes heart damage

Restricting carbohydrates may prevent Alzheimer's disease

Restricting carbohydrates may prevent Alzheimer's disease

Persistent amyloidosis following suppression of Ab production in a transgenic model of Alzheimer disease

Persistent amyloidosis following suppression of Ab production in a transgenic model of Alzheimer disease